Floatz logo

Calcium folinate pentahydrate

B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

National Cancer Institute (NCI)Small moleculePhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
81/ 100

Competitive context

9 Active assets in the B Acute Lymphoblastic Leukemia, BCR-ABL1-Like cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
University of Washington
Phase 3BB
DEXAMETHASONE
Novartis Pharmaceuticals
Phase 3BB
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BB
Cyclophosphamide
SWOG Cancer Research Network
Phase 3BB

View all 13 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →